S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › MRAT › Research report
← MRAT page
XStocksXray
Market X-Ray report · 19 October 2026

Mustika Ratu Tbk (MRAT)

Jakarta Exchange · Indonesia · prices in IDR · close of 19 Oct 2026

Key indicators

Last closeIDR 380.00
52-week range340.00 – 755.00
Return, 1 month / 3 months+6.7% / −13.6%
Return, 1 year / 3 years−10.4% / −22.4%
TrendBelow its 200-day average
RSI (14)45
Volatility (1 year)55.3%
Worst drawdown (1 year)-50.8%
Average daily value traded235.91M IDR
Dividend yield–

Market X-Ray price-based

48/ 100 · High confidence · ahead of 48% of stocks on this exchange
Trend50
Momentum51
Stability (higher is calmer)55
Liquidity31
Income–

Five-year price chart navy: price · brown: 200-day average

1323405497579652021-102023-012024-042025-082026-10

About the company

Mustika Ratu Tbk is an Indonesian company that makes cosmetics, skincare products and traditional herbal remedies known as jamu. Its range covers beauty treatments, body care and health drinks inspired by Indonesian herbal traditions. The company serves consumers in Indonesia and also exports some products to overseas markets. It is based in Jakarta and sells through retailers, distributors and its own outlets, drawing on local plant ingredients and traditional recipes in the products it develops and markets.

On this site Mustika Ratu Tbk appears as a stock on the Jakarta Exchange (Indonesia), code MRAT, with prices in Indonesian rupiah (IDR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Mustika Ratu Tbk (MRAT) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 380.00 on 19 October 2026.

Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 485 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 10.4% and over the last three months it fell 13.6%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Mustika Ratu Tbk (MRAT)

The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange

Lens and metricValueScoreReading
Trend50 · FairMixed trend against its averages.
Above 200-day average-11.6%
From 52-week high-46.9%
Momentum51 · FairTypical recent returns for this exchange.
3-month return-13.6%
6-month return-6.9%
12-month return, skipping the last month-16.0%
Stability (higher is calmer)55 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)55.3%
Worst drawdown, 1 year (smaller is calmer)-50.8%
Liquidity31 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded235.91M IDR
Zero-volume days3.3%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−1.0%
1 month+6.7%
3 months−13.6%
6 months−6.9%
1 year−10.4%
3 years−22.4%
5 years–

Signals

50-day / 200-day average397.44 / 429.77
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)25.10

Technical summary

DailyStrongly bearish1 bullish · 4 neutral · 11 bearish
WeeklyStrongly bearish1 bullish · 1 neutral · 10 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026